Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Terminated1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated133%
completed133%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Sleep, Light, Circadian, Central Oxidative Stress

NCT07471126
completednot_applicable

Cardiometabolic Outcomes With Light Exposure During Sleep

NCT05317559
terminatednot_applicable

Impact of Daylight on Patients With Acute Myocardial Infarction

NCT02490397

Clinical Trials (3)

Showing 3 of 3 trials
NCT07471126Not Applicable

Sleep, Light, Circadian, Central Oxidative Stress

Not Yet Recruiting
NCT05317559Not Applicable

Cardiometabolic Outcomes With Light Exposure During Sleep

Completed
NCT02490397Not Applicable

Impact of Daylight on Patients With Acute Myocardial Infarction

Terminated

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3